ME1111

· Meiji Seika Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ME1111, covering 2013-12-17 to 2024-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of ME1111 in Patients With Onychomycosis [Phase 2]